Bellerophon Therapeutics Inc (BLPH):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Bellerophon Therapeutics Inc (BLPH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8309
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Bellerophon Therapeutics LLC is a clinical-stage biotherapeutics company that focuses on the development of therapies for the treatment of cardiopulmonary diseases. The company’s lead investigational cardiopulmonary product candidate, INOpulse, a combination drug-device therapy intended for the treatment of pulmonary hypertension associated with interstitial lung disease, pulmonary hypertension associated with sarcoidosis and pulmonary hypertension associated with chronic obstructive pulmonary disease. It develops INOpulse platform is based on its proprietary pulsatile nitric oxide delivery device. Bellerophon Therapeutics is headquartered in Warren, New Jersey, the US.

Bellerophon Therapeutics Inc (BLPH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bellerophon Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Bellerophon Therapeutics Raises Funds through Venture Financing 11
Bellerophon Therapeutics Raises Funds Through Venture Financing 12
Bellerophon Therapeutics Secures USD80 Million in Venture Funding 13
Equity Offering 14
Bellerophon Therapeutics Plans to Raise up to USD100 Million in Public offering of Securities 14
Bellerophon Therapeutics Plans to Raise Funds through Public Offering 15
Bellerophon Therapeutics Raises USD23.4 Million in Private Placement of Units 16
Bellerophon Therapeutics Raises USD3 Million in Private Placement of Shares and Warrants 18
Bellerophon Therapeutics Raises USD12 Million in Public Offering of Shares 19
Bellerophon Therapeutics Raises USD60 Million in IPO 20
Bellerophon Therapeutics Inc – Key Competitors 22
Bellerophon Therapeutics Inc – Key Employees 23
Bellerophon Therapeutics Inc – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Financial Announcements 25
Aug 01, 2018: Bellerophon provides business update and reports second quarter 2018 financial results 25
May 10, 2018: Bellerophon Provides Business Update and Reports First Quarter 2018 Financial Results 27
Mar 15, 2018: Bellerophon Reports Fourth Quarter and Full-Year 2017 Financial Results 29
Nov 07, 2017: Bellerophon Provides Business Update and Reports Third Quarter 2017 Financial Results 31
Aug 07, 2017: Bellerophon Reports Second Quarter 2017 Financial Results and Provides Business Update 33
May 15, 2017: Bellerophon Reports First Quarter 2017 Financial Results and Provides Business Update 35
Mar 13, 2017: Bellerophon Reports Fourth Quarter 2016 Financial Results and Provides Business Update 37
Corporate Communications 39
Nov 30, 2017: Bellerophon Appoints Ted Wang, Ph.D., of Puissance Capital Management, to its Board of Directors 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bellerophon Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Bellerophon Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Bellerophon Therapeutics Raises Funds through Venture Financing 11
Bellerophon Therapeutics Raises Funds Through Venture Financing 12
Bellerophon Therapeutics Secures USD80 Million in Venture Funding 13
Bellerophon Therapeutics Plans to Raise up to USD100 Million in Public offering of Securities 14
Bellerophon Therapeutics Plans to Raise Funds through Public Offering 15
Bellerophon Therapeutics Raises USD23.4 Million in Private Placement of Units 16
Bellerophon Therapeutics Raises USD3 Million in Private Placement of Shares and Warrants 18
Bellerophon Therapeutics Raises USD12 Million in Public Offering of Shares 19
Bellerophon Therapeutics Raises USD60 Million in IPO 20
Bellerophon Therapeutics Inc, Key Competitors 22
Bellerophon Therapeutics Inc, Key Employees 23

List of Figures
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bellerophon Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Bellerophon Therapeutics Inc (BLPH):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • bluebird bio Inc (BLUE):企業の財務・戦略的SWOT分析
    bluebird bio Inc (BLUE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Determine Inc (DTRM):企業の財務・戦略的SWOT分析
    Summary Determine Inc (Determine), formerly Selectica Inc and a subsidiary of Corcentric, is a technology company. The company provides SaaS source-to-pay and enterprise contract lifecycle management solutions. It offers solutions such as strategic sourcing, supplier management; procure to pay, invo …
  • Jordan French Insurance Co. (P.L.C.):企業の戦略・SWOT・財務情報
    Jordan French Insurance Co. (P.L.C.) - Strategy, SWOT and Corporate Finance Report Summary Jordan French Insurance Co. (P.L.C.) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • United Utilities Group Plc (UU):電力:M&Aディール及び事業提携情報
    Summary United Utilities Group PLC (United Utilities) is a provider of water and wastewater services. It gathers water from reservoirs, lakes, boreholes and streams; and collects and treats wastewater, and deposits it into rivers and sea. The company extracts water from Lake Vyrnwy in Wales for cust …
  • Success Universe Group Limited:企業の戦略・SWOT・財務分析
    Success Universe Group Limited - Strategy, SWOT and Corporate Finance Report Summary Success Universe Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • InnoMedica Holding AG-製薬・医療分野:企業M&A・提携分析
    Summary InnoMedica Holding AG (InnoMedica) discovers and develops therapeutics for the treatment of cancer. The company develops drugs using its proprietary drug delivery technology, Talidox, based on the transport and release of active pharmaceutical agents, locally, at the target area. Its pipelin …
  • Euticals SpA-製薬・医療分野:企業M&A・提携分析
    Summary Euticals SpA (Euticals) is a chemical company that develops and supplies active pharmaceutical ingredients, fine chemicals and contract manufacturing. The company possess technologies and capabilities in the domains of fermentation and enzymatic chemistry; boronic acids, biaryls, grignards a …
  • CLP Holdings Limited:企業の戦略・SWOT・財務分析
    CLP Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary CLP Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Hitachi Ltd (6501):企業の財務・戦略的SWOT分析
    Hitachi Ltd (6501) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Alpine Immune Sciences Inc (NVLS):企業の財務・戦略的SWOT分析
    Summary Alpine Immune Sciences Inc (Alpine), formerly Nivalis Therapeutics Inc, is a pharmaceutical company that discovering and developing innovative, protein-based immunotherapies, immune synapse to treat cancer and autoimmune and inflammatory diseases. The has two products in the clinic for infla …
  • Senzime AB (SEZI):企業の財務・戦略的SWOT分析
    Summary Senzime AB (Senzime) is a medical device company that develops patient-oriented monitoring systems. The company's product include TetraGraph monitor, CliniSenz analyzer, and Onzurf probe. Its TetraGraph monitor stimulates, measures, analyzes and displays muscle function in surgical patients …
  • Raya Holding (RAYA):企業の財務・戦略的SWOT分析
    Raya Holding (RAYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Industrias Metalurgicas Pescarmona SA:企業の戦略的SWOT分析
    Industrias Metalurgicas Pescarmona SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Al Hassan Engineering Co (HECI):企業の財務・戦略的SWOT分析
    Al Hassan Engineering Co (HECI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Hermes Europe GmbH:企業の戦略的SWOT分析
    Hermes Europe GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • iNova Pharmaceuticals (Australia) Pty Ltd:企業の戦略的SWOT分析
    iNova Pharmaceuticals (Australia) Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Qatar Electricity & Water Co QPSC (QEWS):企業の財務・戦略的SWOT分析
    Qatar Electricity & Water Co QPSC (QEWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Hutchison Telecommunications (Australia) Limited (HTA):企業の財務・戦略的SWOT分析
    Hutchison Telecommunications (Australia) Limited (HTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s …
  • The Cleveland Clinic Foundation:企業の戦略的SWOT分析
    The Cleveland Clinic Foundation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Genomind Inc:医療機器:M&Aディール及び事業提携情報
    Summary Genomind Inc (Genomind) is a personalized medicine company that provides genetic testing services. The company offers Genecept Assay, a pharmacogenetic test designed to help clinicians optimize treatment decisions for their patients with mental illness. Its test is used to guide treatment fo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆